Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Scientific reports ; 9, Heft 1 (7.2.2019), 1-10, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Lee, Eun Byul
Kim, Jung-Hee
Hur, Wonhee
Choi, Jung Eun
Kim, Sung Min
Park, Dong Jun
Kang, Byung-Yoon
Lee, Gil Won
Yoon, Seung Kew
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-38533-7
- URN
-
urn:nbn:de:101:1-2019043019574333571395
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Eun Byul
- Kim, Jung-Hee
- Hur, Wonhee
- Choi, Jung Eun
- Kim, Sung Min
- Park, Dong Jun
- Kang, Byung-Yoon
- Lee, Gil Won
- Yoon, Seung Kew
- SpringerLink (Online service)
Other Objects (12)
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Production in Pichia pastoris and characterization of genetically engineered hepatitis B surface antigen virus-like particles
Engineered virus-like particles: paving the way for effective somatic genome editing
Ebola virus–like particles reprogram cellular metabolism
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Modeling the Stability of Protein Solutions and of Hepatitis B Virus-Like Particles
Induktion Epstein-Barr-Virus-spezifischer Immunantworten durch Exosomen und virus-like particles
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Generierung von Virus-like Particles (VLPs) aus rekombinantem Woodchuck-Hepatitis-Virus (WHV) Core-Antigen und Testung der Immunogenität